These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 10694824)

  • 1. Angiogenesis induced by hepatocyte growth factor in non-infarcted myocardium and infarcted myocardium: up-regulation of essential transcription factor for angiogenesis, ets.
    Aoki M; Morishita R; Taniyama Y; Kida I; Moriguchi A; Matsumoto K; Nakamura T; Kaneda Y; Higaki J; Ogihara T
    Gene Ther; 2000 Mar; 7(5):417-27. PubMed ID: 10694824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic angiogenesis induced by human hepatocyte growth factor gene in rat and rabbit hindlimb ischemia models: preclinical study for treatment of peripheral arterial disease.
    Taniyama Y; Morishita R; Aoki M; Nakagami H; Yamamoto K; Yamazaki K; Matsumoto K; Nakamura T; Kaneda Y; Ogihara T
    Gene Ther; 2001 Feb; 8(3):181-9. PubMed ID: 11313789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo evidence of angiogenesis induced by transcription factor Ets-1: Ets-1 is located upstream of angiogenesis cascade.
    Hashiya N; Jo N; Aoki M; Matsumoto K; Nakamura T; Sato Y; Ogata N; Ogihara T; Kaneda Y; Morishita R
    Circulation; 2004 Jun; 109(24):3035-41. PubMed ID: 15173033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo transfer of human hepatocyte growth factor gene accelerates re-endothelialization and inhibits neointimal formation after balloon injury in rat model.
    Hayashi K; Nakamura S; Morishita R; Moriguchi A; Aoki M; Matsumoto K; Nakamura T; Kaneda Y; Sakai N; Ogihara T
    Gene Ther; 2000 Oct; 7(19):1664-71. PubMed ID: 11083475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiogenic gene cell therapy using suicide gene system regulates the effect of angiogenesis in infarcted rat heart.
    Miyagawa S; Sawa Y; Fukuda K; Hisaka Y; Taketani S; Memon IA; Matsuda H
    Transplantation; 2006 Mar; 81(6):902-7. PubMed ID: 16570015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficient in vivo gene transfer into the heart in the rat myocardial infarction model using the HVJ (Hemagglutinating Virus of Japan)--liposome method.
    Aoki M; Morishita R; Muraishi A; Moriguchi A; Sugimoto T; Maeda K; Dzau VJ; Kaneda Y; Higaki J; Ogihara T
    J Mol Cell Cardiol; 1997 Mar; 29(3):949-59. PubMed ID: 9152856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatocyte growth factor and granulocyte colony-stimulating factor form a combined neovasculogenic therapy for ischemic cardiomyopathy.
    Guo YH; He JG; Wu JL; Yang L; Zhang DS; Tan XY; Qi RD
    Cytotherapy; 2008; 10(8):857-67. PubMed ID: 18956268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo gene transfection with hepatocyte growth factor via the pulmonary artery induces angiogenesis in the rat lung.
    Ono M; Sawa Y; Matsumoto K; Nakamura T; Kaneda Y; Matsuda H
    Circulation; 2002 Sep; 106(12 Suppl 1):I264-9. PubMed ID: 12354744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel therapeutic strategy to treat brain ischemia: overexpression of hepatocyte growth factor gene reduced ischemic injury without cerebral edema in rat model.
    Shimamura M; Sato N; Oshima K; Aoki M; Kurinami H; Waguri S; Uchiyama Y; Ogihara T; Kaneda Y; Morishita R
    Circulation; 2004 Jan; 109(3):424-31. PubMed ID: 14707023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of acute myocardial infarction by hepatocyte growth factor gene transfer: the first demonstration of myocardial transfer of a "functional" gene using ultrasonic microbubble destruction.
    Kondo I; Ohmori K; Oshita A; Takeuchi H; Fuke S; Shinomiya K; Noma T; Namba T; Kohno M
    J Am Coll Cardiol; 2004 Aug; 44(3):644-53. PubMed ID: 15358035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of safe and efficient novel nonviral gene transfer using ultrasound: enhancement of transfection efficiency of naked plasmid DNA in skeletal muscle.
    Taniyama Y; Tachibana K; Hiraoka K; Aoki M; Yamamoto S; Matsumoto K; Nakamura T; Ogihara T; Kaneda Y; Morishita R
    Gene Ther; 2002 Mar; 9(6):372-80. PubMed ID: 11960313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adenovirus-mediated gene transfer into infarcted myocardium: feasibility, timing, and location of expression.
    Leor J; Quiñones MJ; Patterson M; Kedes L; Kloner RA
    J Mol Cell Cardiol; 1996 Oct; 28(10):2057-67. PubMed ID: 8930802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiogenic and antifibrotic actions of hepatocyte growth factor improve cardiac dysfunction in porcine ischemic cardiomyopathy.
    Azuma J; Taniyama Y; Takeya Y; Iekushi K; Aoki M; Dosaka N; Matsumoto K; Nakamura T; Ogihara T; Morishita R
    Gene Ther; 2006 Aug; 13(16):1206-13. PubMed ID: 16625244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experimental study of bone marrow-derived mesenchymal stem cells combined with hepatocyte growth factor transplantation via noninfarct-relative artery in acute myocardial infarction.
    Yang ZJ; Ma DC; Wang W; Xu SL; Zhang YQ; Chen B; Zhou F; Zhu TB; Wang LS; Xu ZQ; Zhang FM; Cao KJ; Ma WZ
    Gene Ther; 2006 Nov; 13(22):1564-8. PubMed ID: 16810195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiogenesis induced by endothelial nitric oxide synthase gene through vascular endothelial growth factor expression in a rat hindlimb ischemia model.
    Namba T; Koike H; Murakami K; Aoki M; Makino H; Hashiya N; Ogihara T; Kaneda Y; Kohno M; Morishita R
    Circulation; 2003 Nov; 108(18):2250-7. PubMed ID: 14568906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of onset of Parkinson's disease by in vivo gene transfer of human hepatocyte growth factor in rodent model: a model of gene therapy for Parkinson's disease.
    Koike H; Ishida A; Shimamura M; Mizuno S; Nakamura T; Ogihara T; Kaneda Y; Morishita R
    Gene Ther; 2006 Dec; 13(23):1639-44. PubMed ID: 16791285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transfection of human hepatocyte growth factor gene ameliorates secondary lymphedema via promotion of lymphangiogenesis.
    Saito Y; Nakagami H; Morishita R; Takami Y; Kikuchi Y; Hayashi H; Nishikawa T; Tamai K; Azuma N; Sasajima T; Kaneda Y
    Circulation; 2006 Sep; 114(11):1177-84. PubMed ID: 16952986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene transfection with human hepatocyte growth factor complementary DNA plasmids attenuates cardiac remodeling after acute myocardial infarction in goat hearts implanted with ventricular assist devices.
    Shirakawa Y; Sawa Y; Takewa Y; Tatsumi E; Kaneda Y; Taenaka Y; Matsuda H
    J Thorac Cardiovasc Surg; 2005 Sep; 130(3):624-32. PubMed ID: 16153905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of angiogenesis and inhibition of apoptosis by hepatocyte growth factor effectively treats postischemic heart failure.
    Jayasankar V; Woo YJ; Pirolli TJ; Bish LT; Berry MF; Burdick J; Gardner TJ; Sweeney HL
    J Card Surg; 2005; 20(1):93-101. PubMed ID: 15673421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amelioration of pulmonary emphysema by in vivo gene transfection with hepatocyte growth factor in rats.
    Shigemura N; Sawa Y; Mizuno S; Ono M; Ohta M; Nakamura T; Kaneda Y; Matsuda H
    Circulation; 2005 Mar; 111(11):1407-14. PubMed ID: 15781752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.